Single User License
INR 168725
Site License
INR 337450
Corporate User License
INR 506175

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Hemostasis Global Clinical Trials Review, H1

Hemostasis Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Hemostasis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Hemostasis Global Clinical Trials Review, H1, 2015" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Hemostasis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Hemostasis to Hematological Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Hemostasis to Hematological Disorders Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Hemostasis 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Hemostasis Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

Baxter International Inc. 32

Clinical Trial Overview of Baxter International Inc. 32

Takeda Pharmaceutical Company Limited 33

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33

Johnson & Johnson 34

Clinical Trial Overview of Johnson & Johnson 34

Novo A/S 35

Clinical Trial Overview of Novo A/S 35

Grifols, S.A. 36

Clinical Trial Overview of Grifols, S.A. 36

ZymoGenetics, Inc. (Inactive) 37

Clinical Trial Overview of ZymoGenetics, Inc. (Inactive) 37

The Medicines Company 38

Clinical Trial Overview of The Medicines Company 38

LAL Clinica Pesquisa e Desenvolvimento Ltda 39

Clinical Trial Overview of LAL Clinica Pesquisa e Desenvolvimento Ltda 39

Teva Pharmaceutical Industries Limited 40

Clinical Trial Overview of Teva Pharmaceutical Industries Limited 40

Omrix Biopharmaceuticals, Inc. (Inactive) 41

Clinical Trial Overview of Omrix Biopharmaceuticals, Inc. (Inactive) 41

Clinical Trial Overview of Top Institutes / Government 42

Radboud University 42

Clinical Trial Overview of Radboud University 42

Academic Medical Center 43

Clinical Trial Overview of Academic Medical Center 43

Austin Health 44

Clinical Trial Overview of Austin Health 44

Azienda Ospedaliera Universitaria Senese 45

Clinical Trial Overview of Azienda Ospedaliera Universitaria Senese 45

Azienda Unita Sanitaria Locale Lecce 46

Clinical Trial Overview of Azienda Unita Sanitaria Locale Lecce 46

Bassett Healthcare 47

Clinical Trial Overview of Bassett Healthcare 47

Capital District Health Authority, Canada 48

Clinical Trial Overview of Capital District Health Authority, Canada 48

Eidgenossische Technische Hochschule Zurich 49

Clinical Trial Overview of Eidgenossische Technische Hochschule Zurich 49

Esbjerg Dentallaboratorium Aps 50

Clinical Trial Overview of Esbjerg Dentallaboratorium Aps 50

Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 51

Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 51

Five Key Clinical Profiles 52

Appendix 90

Abbreviations 90

Definitions 90

Research Methodology 91

Secondary Research 91

About GlobalData 92

Contact Us 92

Disclaimer 92

Source 93

List of Figures

Hemostasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Hemostasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hemostasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hemostasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Hemostasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Hemostasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Hemostasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Hemostasis to Hematological Disorders Clinical Trials, G7 Countries (%), 2015* 15

Hemostasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Hemostasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Hemostasis to Hematological Disorders Clinical Trials, E7 Countries (%), 2015* 18

Hemostasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Hemostasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Hemostasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Hemostasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Hemostasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Hemostasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Hemostasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Hemostasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Hemostasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Hemostasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Hemostasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 91

List of Tables

Hemostasis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Hemostasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hemostasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hemostasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Hemostasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Hemostasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Hemostasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Hemostasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Hemostasis to Hematological Disorders Clinical Trials, G7 Countries (%), 2015* 15

Hemostasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Hemostasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Hemostasis to Hematological Disorders Clinical Trials, E7 Countries (%), 2015* 18

Hemostasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Hemostasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Hemostasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Hemostasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Hemostasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Hemostasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Hemostasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Hemostasis Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Hemostasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Hemostasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Hemostasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Hemostasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Hemostasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 32

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 33

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 34

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 35

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2015* 36

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by ZymoGenetics, Inc. (Inactive), 2015* 37

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medicines Company, 2015* 38

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by LAL Clinica Pesquisa e Desenvolvimento Ltda, 2015* 39

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2015* 40

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Omrix Biopharmaceuticals, Inc. (Inactive), 2015* 41

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015* 42

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 43

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015* 44

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Senese, 2015* 45

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Unita Sanitaria Locale Lecce, 2015* 46

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bassett Healthcare, 2015* 47

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2015* 48

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eidgenossische Technische Hochschule Zurich, 2015* 49

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Esbjerg Dentallaboratorium Aps, 2015* 50

Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2015* 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Baxter International Inc.

Takeda Pharmaceutical Company Limited

Johnson & Johnson

Novo A/S

Grifols, S.A.

The Medicines Company

LAL Clinica Pesquisa e Desenvolvimento Ltda

Teva Pharmaceutical Industries Limited

Hemostasis Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Hemostasis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com